CIK 0001737953
- Non-accelerated filer
- Smaller reporting company
Replimune Group, Inc.
Sign in to watch- Ticker
- REPL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Mar 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 822082553
- Phone
- +1 781-222-9600
- Business address
- 500 UNICORN PARK, WOBURN, MA, 01801
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $521,860
- in 2 filings
Net −$521,860. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 83 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-12-14 | Franchi Jean M. Chief Financial Officer | Option exercise | +25,000 | $14.08 | $352K | 25,000 |
| 2020-12-14 | Franchi Jean M. Chief Financial Officer | Sale | −17,856 | $43.70 | $780K | 7,144 |
| 2020-12-14 | Franchi Jean M. Chief Financial Officer | Sale | −6,755 | $42.86 | $290K | 389 |
| 2020-12-14 | Franchi Jean M. Chief Financial Officer | Sale | −389 | $42.09 | $16K | 0 |
| 2020-12-14 | Franchi Jean M. Chief Financial Officer | Option exercise · Employee Stock Option (right to buy) | −25,000 | 155,000 |
Page 19 of 19 · 365 trades